PROVIDER PROFILE · NPI 1013005321

Paul LarsonM.D.

PRACTICEUNIVERSITY OF ARIZONASee all providers at this practice →

NeurosurgeryTucson, AZI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$16K

Peer benchmark

Total Medicare services vs. 111 Neurosurgery providers in AZ — bottom quintile (cohort median 428).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$89

Distinct drugs

Brand share

100.0%

Top prescribed drugs

Hydrocodone/Acetaminophen16 claims

QUALITY · MIPS · 2024

Final MIPS score

93.3

Quality

74.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.77%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$11K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$8K

Food and Beverage$1K

Consulting Fee$920

Travel and Lodging$50

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 030064

Hospital

REFERRAL NETWORK

Where Paul Larson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO	61	248
Jill Ostrem Neurology · San Francisco, CA	15	96

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history